Nebulizers in childhood

European Respiratory Review

Volumn 10, Issue 76, 2000, Pages 527-535

  Barry, P W ^a   Fouroux, B ^a   Pedersen, S ^a   O'Callaghan, C ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Asthma; Nebulizers and vaporisers; Paediatrics

Indexed keywords

ACETYLCYSTEINE; ADRENALIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEOXYRIBONUCLEASE; FUROSEMIDE; IPRATROPIUM BROMIDE; LUNG SURFACTANT; PROSTACYCLIN; RIBAVIRIN;

ASTHMA; BREATHING PATTERN; BRONCHIOLITIS; CHILD; CONFERENCE PAPER; CROUP; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FACE MASK; GAS FLOW; HUMAN; METERED DOSE INHALER; NEBULIZER; PATIENT COMPLIANCE; TIDAL VOLUME; TREATMENT INDICATION;

EID: 0034493772     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (108)

1. European trends in inhalation therapy
2. Inhalation therapy in asthma: Nebulizer orpressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children
3. Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma
4. Guidelines for the management of asthma
5. The influence of age on aerosol deposition in children with cystic fibrosis
6. Aerosol deposition in infants with cystic fibrosis
7. Crying significantly reduces absorption of aerosolised drug in infants
8. Patient related factors in nebulized drug delivery to children
9. Dilution of nebulized aerosols by air entrainment in children
10. Improving the efficiency of drug administration with jet nebulisers
11. How much aerosol reaches the lungs of wheezy infants and toddlers?
12. Systemic availability and pharmacokinetics of nebulised budesohide in preschool children
13. The systemic exposure of budesonide inhaled from a metal spacer is similar in young children and adults
14. Aerosol penetration into the lung; influence on airway responses
15. The effect of aerosol distribution on airway responsiveness to inhaled methacholine in patients with asthma
16. Influence of inspiratory flow rate on the bronchial response to ultrasonic mist of distilled water in asthmatic patients
17. Nebulised sodium cromoglycate in infancy: Airway protection after deterioration
18. North of England evidence based guidelines development project: Methods of guideline development
19. High versus low dose, frequently administered, nebulized albuterol in children with severe, acute asthma
20. 2 in children with severe asthma treated with continuously nebulised terbutaline
21. Continuous terbutaline nebulisation for treatment of severe asthma in children
22. Continuous nebulization for status asthmaticus
23. Safety of continuous nebulized albuterol for bronchospasm in infants and children
24. Continuous versus intermittent nebulized terbutaline: Plasma levels and effects
25. Continuous nebulised salbutamol and oral once a day prednisolone in status asthmaticus
26. A prospective, randomised study of continuous versus intermittent nebulised albuterol for severe status asthmaticus in children
27. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild to moderate acute pediatric asthma
28. Continuous vs intermittent nebulized albuterol for emergency management of asthma
29. Holding chambers versus nebulisers for beta agonist treatment of acute asthma (Cochrane Review)
30. When drug therapy for lung disease affects the heart
31. Substitution of metered dose inhalers for hand held nebulisers: Success and cost savings in a large acute care hospital
32. Asthma therapy with aerosols: Are nebulizers obsolete? A continuing controversy
33. Nebuhaler vs Nebuliser in children with acute asthma
34. Comparative efficacy of terbutaline administered by Nebuhaler and by nebulizer in young children with acute asthma
35. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants
36. Effect of salbutamol on oxygen saturation in bronchiolitis
37. Airway responsiveness in wheezy infants: Evidence for functional beta adrenergic receptors
38. Nebulised salbutamol does have a protective effect on airways in children under 1 year old
39. Controlled trial of nebulised albuterol in children younger than 2 years of age with acute asthma
40. Ipratropium bromide added to asthma treatment in the pediatric emergency department
41. Effect of nebulized ipratropium on the hospitalization rates of children with asthma
42. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma
43. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma
44. Anticholinergic drugs for wheeze in children under the age of two years (Cochrane Review)
45. Efficacy of adding nebulised ipratropium bromide to nebulized albuterol in acute bronchiolitis
46. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: A controlled comparative study with oral prednisolone
47. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: A randomized controlled trial
48. Inhaled flunisolide for acute severe asthma
49. Nebuhaler versus wet aerosol for domiciliary bronchodilator therapy. A multi-centre clinical comparison
50. A dose response study of inhaled terbutaline administered via nebuhaler or nebuliser to asthmatic children
51. Pulmonary response to a bronchodilator delivered from three inhalation devices
52. Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life
53. Bronchodilator therapy in bronchiolitis (Cochrane Review)
54. Efficacy of beta 2 agonists in bronchiolitis: A reappraisal and meta analysis
55. The use of albuterol in hospitalized infants with bronchiolitis
56. Pediatric myocardial infarction after racemic epinephrine administration
57. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing
58. Ribavirin for RSV lower respiratory tract infection (Cochrane Review)
59. Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial
60. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections
61. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection
62. Aerosolised ribavirin in mechanically ventilated children wtih respiratory syncytial virus lower respiratory tract disease: A prospective, double-blind, randomized trial
63. Management of childhood croup
64. Inhaled budesonide and adrenalin for croup
65. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup
66. Nebulized budsonide and oral dexamethasone for treatment of croup: A randomized controlled trial
67. Effect of beta agonist nebulisation in neonates with increased pulmonary resistance
68. Early onset of pulmonary reactivity in premature infants with bronchopulmonary dysplasia
69. Effects of bronchodilators on airway resistance in ventilator-dependent infants with chronic lung disease
70. Effect of nebulized salbutamol in preterm infants during the first year of life
71. Inhaled salbutamol and beclomethasone for preventing bronchopulmonary dysplasia: A randomized double-blind study
72. Randomised crossover trial of salbutamol aerosol delivered by metered dose inhaler, jet nebuliser, and ultrasonic nebuliser in chronic lung disease
73. Effects of inhaled metaproterenol and atropine on the pulmonary mechanics of infants with bronchopulmonary dysplasia
74. Bronchodilator response to ipratropium bromide in infants with bronchopulmonary dysplasia
75. Ipratropium bromide for symptomatic preterm infants
76. Cerebral blood flow velocity changes after rapid administration of surfactant
77. Surfactant nebulisation prevents the adverse effects of surfactant therapy on blood pressure and cerebral blood flow in rabbits with severe respiratory failure
78. Nebulized vs. instilled exogenous surfactant in an adult lung injury model
79. Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury
80. Aerosolized surfactant treatment of preterm lambs
81. Aerosolized surfactant reverses respiratory failure in lung-lavaged rats
82. Nebulization of surfactants in an animal model of neonatal respiratory distress
83. Dexamethasone therapy in neonatal chronic lung disease: An international placebo controlled trial
84. Randomised trial of inhaled steroids in preterm infants with respiratory symptoms at follow up
85. Nebulised steroid therapy in bronchopulmonary dysplasia
86. Controlled trial of beclomethasone dipropionate by nebulisation in oxygen and ventilator dependent infants
87. Effectiveness of budesonide aerosol in ventilator dependent preterm babies: A preliminary report
88. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia
89. The effect of aerosolized furosemide in infants with chronic lung disease
90. Pulmonary function changes after nebulised and intravenous frusemide in ventilated premature infants
91. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia
92. Safety of endotracheal rh DNase (Pulmozyme) for treatment of pulmonary atelectasis in mechanically ventilated children
93. Dornase alpha in the management of a mechanically ventilated infant with cystic fibrosis
94. Effect of mucolytic and bronchodilator aerosol therapy on airway resistance in mechanically ventilated patients
95. Natural surfactant aerosolisation in adult respiratory distress syndrome
96. Effects of aerosolized surfactant in patients with stable chronic bronchitis: A prospective randomized controlled trial
97. Physiologic response and distribution of aerosolized suffactant (Survanta) in a non-uniform pattern of lung injury
98. Dexamethasone for the prevention of postexubation airway obstruction: A prospective, randomized, double-blind, placebo-controlled trial
99. Effectiveness of dexamethasone in preventing extubation failure in preterm infants at increased risk for airway edema
100. Steroids for anything that swells: Dexamethasone and postintubation airway obstruction
101. New therapy for postintubation laryngeal edema and tracheitis in children
102. Racemic versus L-epinephrine aerosol in the treatment of postextubation laryngeal edema: Results of a prospective, randomised, double blind study
103. Aerosolised prostacyclin and iloprost in severe pulmonary hypertension
104. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolised prostacyclin
105. Aerosolised soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury
106. Measuring compliance with inhaled medication in asthma
107. Noncompliance and treatment failure in children with asthma
108. Adaptive aerosol delivery: The principles